Skip to content
Sharism- Lifestyle
Author:
Astrocyte Pharmaceuticals Inc.
Astrocyte Pharmaceuticals Secures $9.5 Million Series B to Advance Phase 2 Clinical Development of Breakthrough TBI and Concussion Therapy AST-004
September 30, 2026